BCR-ABL mutation testing to predict response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Lignende værker

• Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
  af: de Almeida, Maria Helena, et al.
  Udgivet: (2014)
• Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
  af: Takeuchi, Asako, et al.
  Udgivet: (2020)
• Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors
  af: Gabriel Etienne, et al.
  Udgivet: (2019-09-01)
• Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors
  af: Etienne, Gabriel, et al.
  Udgivet: (2019)
• CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic
  af: Dahabreh, Issa, et al.
  Udgivet: (2010)